Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Translational Psychiatry|February 9, 2022
A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorderAndreas Göteson, Anniella Isgren, Timea Sparding, et al.
Brain, Behavior, and Immunity|May 10, 2017
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomesAnniella Isgren, Carl Sellgren, Carl-Johan Ekman, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal FluidKarl T Hansson, Tobias Skillbäck, Elin Pernevik, et al.
Biological Psychiatry Global Open Science|October 26, 2023
Alterations in the Serum Proteome Following Electroconvulsive Therapy for a Major Depressive Episode: A Longitudinal Multicenter StudyAndreas Göteson, Caitlin C Clements, Anders Juréus, et al.
Molecular Psychiatry|August 5, 2021
Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorderAndreas Göteson, Anniella Isgren, Lina Jonsson, et al.
Journal of Proteome Research|December 10, 2014
An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseMikko Hölttä, Lennart Minthon, Oskar Hansson, et al.
Molecular Psychiatry|August 19, 2022
Cerebrospinal fluid proteomic study of two bipolar disorder cohortsAnniella Isgren, Andreas Göteson, Jessica Holmén-Larsson, et al.
Proteomics|January 4, 2017
Expanding the cerebrospinal fluid endopeptidomeKarl T Hansson, Tobias Skillbäck, Elin Pernevik, et al.
Pageof 2